Dr. Lina El Kibbi 🩺 د. لينا فيصل الكبي
@linakibbeاستشارية روماتيزم و مدير شؤون التعليم الطبي| 📍 🇸🇦 | مؤسس المجموعة العربية للتوعية بالأمراض الروماتيزمية في الوطن العربي Public Speaker | #Rheumatologist |
Similar User
@mfa9el
@KhaledAlderaan
@rayes_dr
@AlhomoodIbrahim
@rheumatism_sa
@A_alkhalaf143
@rheumatoid_
@foap_shj
@Dr_NawalBassuni
@AlkhalifahDr
@AlhussainMAsiri
@Ralsolaimani
@sulaimanm2020
@DrArfajAbdLatif
@fibromyalgiafi1
الحمد لله الذي بنعمته تتم الصالحات،لقد تم حصولي على #الإقامة_المميزة من لا يشكر الناس لا يشكر الله ١٧ سنة في #السعودية شكراً من القلب 🇸🇦 اللهم احفظ المملكة العربية السعودية و وفق قادتها لما فيه خير للبلاد و العباد شكراً على حسن المعاملة من قبل فريق الإقامة المميزة @prgovsa
نظير جهودهم الاستثنائية، منح +2600 إقامة مميزة لكفاءات صحية استثنائية تعمل في المملكة، من أكثر من 50 جنسية. #ملتقى_الصحة_العالمي 2024 #استثمر_في_الصحة
#Neurosarcoidosis proposed treatment (Note: very little RCT data informing this) #ACR24 #Sarcoidosis #methotrexate #antiTNF
#Sjogrens ✴️Patients experience a mutisystem disease process affecting many organs ✴️It is not just SICCA symptoms #ACR24 @SjogrensOrg @NeuroSjogrens @SjogrenEurope
#Vasculitis disease spectrum #ACR24 #AAV #GPA
⚠️Steroids can cause damage *early* in patients with #SLE #ACR24 #Lupus #SLICC #prednisolone
If high +ANA and NO #rheumatic #disease LOOK 👀 at #LIVER #Autoimmune #hepatitis And #alcoholic #liver #dx #ACRBest #ACR24 @rheumnow abst#0627
🆕 The Great Debate at #ACR24: Is Mixed Connective Tissue Disease (MCTD) a distinct disease entity? 🗳️ Final Vote (n=430 votes) • 51% = MCTD *is* a unique disease • 49% = MCTD is not a unique disease @DrLisaCS #MCTD #Rheumatology
#VEXAS symptoms related to #genetic mutations Valine mutation ▶️Higher prevalence of renal involvement Threonine mutation ▶️Deep vein thrombosis ▶️Thrombocytopenia #ACR24 #ACR2024 abstract 2054 👉🏽acrabstracts.org/abstract/pheno…
🔶Clinical Year in Review #ACR24 🔶 Talk By @MHPillingerMD • Review some of the most impactful studies in Rheumatology from the past year! #RheumTwitter #Rheumatology
Talked a little #antiphospholipid history 🧐 before the forward-looking bits 🔮 #ACR24
One of my favorites APS pathophysiology by the one and only @jasonsknight #ACR24 #ACRAmbassador
ASAS definition of Difficult-to-Manage Axial Spondyloarthritis (D2M axSpA) with criteria including treatment failure, suboptimal control, and persistent problematic symptoms. 89% of ASAS members endorsed the definition, including treatment-refractory cases with specific…
🏹How can we optimize the referral of patients with inflammatory rheumatic diseases to #Rheumatology? 👉Check out the ARCH referral algorithm presented this Monday at #ACR24 by @MaroofAvin Poster #1935 #ARCH_ArLAR @ArLARheumatolog
🏹What are the referrals and diagnostic delays for patients with chronic inflammatory rheumatic diseases? 👉Check out the ARCH study in 8 Arab countries presented this Monday by Dr @MaroofAvin at #ACR24 Poster #1936 #ARCH_ArLAR @ArLARheumatolog
What is the frequency and impact of #Fibromyalgia in #PsA cases? Please stop by to visit our #ARCH_ArLAR poster will be presented today at #ACR24 📌 #poster 1229 📍Hall C ⏳10:30 - 12:30 #ArLAR @ArLARheumatolog
What do current national/international rheumatology association guidelines say about perioperative discontinuation of biologics? it's highly, highly variable no wonder people get confused! #ACR24 ABST1037 @CatherineL_Hill @RheumNow
🔍 Distinguishing Difficult-to-Manage from Treatment Refractory: 1️⃣ Failure of ≥2 b/tsDMARDs. 2️⃣ Active disease (ASDAS ≥2.1, CRP+, MRI+, radiographic progression). 3️⃣ Other causes of symptoms are excluded. Striving for clarity in complex cases. @Dr_AndreRibeiro
🩺 ASAS Difficult-to-Manage axSpA Definition: Must meet 3 criteria: 1️⃣ Failure of ≥2 b/tsDMARDs. 2️⃣ Insufficient symptom control (ASDAS ≥2.1, CRP+, MRI+, radiographic progression). 3️⃣ Symptoms perceived as problematic by patients and clinicians. @Dr_AndreRibeiro
🚧 ASAS Roadmap for Difficult-to-Manage axSpA presented brilliantly by Denis: 1️⃣ Definition of D2M axSpA. 2️⃣ Definition of treatment-refractory axSpA. 3️⃣ Recommendations for clinical use. 4️⃣ Research directions. 5️⃣ Interventional studies. @Dr_AndreRibeiro
United States Trends
- 1. Mika 63 B posts
- 2. $CUTO 10,5 B posts
- 3. #IDontWantToOverreactBUT 1.382 posts
- 4. DeVito 15,9 B posts
- 5. Drew Lock 2.489 posts
- 6. DeFi 125 B posts
- 7. #MondayMotivation 19,1 B posts
- 8. #TSTTPDHolidayEssentials 1.479 posts
- 9. Mar-a-Lago 60,1 B posts
- 10. Daikin Park 1.525 posts
- 11. Tommy Cutlets N/A
- 12. Minute Maid Park N/A
- 13. Spirit Airlines 6.918 posts
- 14. Victory Monday 3.968 posts
- 15. #MondayVibes 3.527 posts
- 16. Ratings 28,8 B posts
- 17. Standout 6.807 posts
- 18. Ice Box N/A
- 19. Enron Field N/A
- 20. Good Monday 57,5 B posts
Who to follow
-
دكتور حسين حلبي
@mfa9el -
د.خالد الدرعان | Khaled Alderaan
@KhaledAlderaan -
Dr. Hanan Al Rayes د.حنان الريس
@rayes_dr -
د.إبراهيم الحمود
@AlhomoodIbrahim -
جمعية روماتيزم
@rheumatism_sa -
عبدالعزيز بن ثامر الخلف
@A_alkhalaf143 -
Rheumatoid -روماتويد
@rheumatoid_ -
أصدقاء مرضى إلتهاب المفاصل
@foap_shj -
د.نوال بسيوني
@Dr_NawalBassuni -
Dr. Moayed Alkhalifah - د.مؤيد الخليفة
@AlkhalifahDr -
Dr.Alhussain Asiri,MD,FACP,FACRد/الحسين عسيري
@AlhussainMAsiri -
د. رؤى السليماني
@Ralsolaimani -
د. سليمان المعيوف. Sulaiman M Al-Mayouf, MD
@sulaimanm2020 -
Dr.Abdulatif Alarfaj
@DrArfajAbdLatif -
عن الفايبروميالجيا 💜
@fibromyalgiafi1
Something went wrong.
Something went wrong.